z-logo
open-access-imgOpen Access
Renal Disease Associated with Antiretroviral Therapy in the Treatment of HIV
Author(s) -
Ryan Cooper,
Marcello Tonelli
Publication year - 2011
Publication title -
nephron clinical practice
Language(s) - English
Resource type - Journals
ISSN - 1660-2110
DOI - 10.1159/000321646
Subject(s) - medicine , discontinuation , disease , intensive care medicine , regimen , kidney disease , antiretroviral therapy , health care , public health , human immunodeficiency virus (hiv) , pediatrics , immunology , pathology , viral load , economics , economic growth
The introduction of potent combination antiretroviral therapy (ART) in the treatment of HIV infection has permitted reliable control of disease progression and has markedly improved survival among people with HIV. As a result, health care providers and patients have shifted clinical priorities; whereas once delaying opportunistic illness was a primary focus, increasing emphasis is now placed on preventative health, management of comorbid chronic disease and avoiding long-term toxicities of ART. Although renal disease is common in people with HIV, renal disease specifically due to ART remains relatively rare. Still, as the use of ART continues to increase, health care providers are likely to encounter this potentially serious complication with increasing frequency. Distinguishing ART-related nephrotoxicity from the myriad of other potential causes of renal disease in people with HIV is important in order to avoid unnecessary discontinuation of an appropriate ART regimen. This review focuses on the early recognition of renal disease associated with ART and suggests strategies for management and prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom